$1,000 Genome at Last?

Illumina says its newest sequencing system can churn out whole human genomes for $1,000 apiece.

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

WIKIMEDIA, DOE HUMAN GENOME PROJECTIllumina this week claimed to be the first company to achieve the coveted $1,000 genome. While introducing the firm’s new sequencing systems at the annual JP Morgan Healthcare Conference ongoing in San Francisco, CEO Jay Flatley said that, when used at scale, the new HiSeq X Ten system—which comprises 10 integrated sequencers—can process whole human genomes for $1,000 each. Flatley said that the new machine—which is currently limited to human genomes—can partially sequence five genomes per day and complete 16 whole genomes in just three days, MIT Technology Review reported.

The total price tag represents $800 for reagents, $135 for equipment depreciation over four years, and $65 for overhead, such as staff, according to a cost breakdown posted by Mick Waston, head of bioinformatics at Edinburgh Genomics, on his Opiniomics blog.

According to GenomeWeb Daily News, Illumina is only selling the HiSeq X machines in orders of a minimum 10, for a total cost starting at $10 million. The Seoul-based company Macrogen, Australia’s Garvan Institute of Medical Research, and the Broad Institute of MIT and Harvard placed the first three orders for the system.

“Over the next few years, we have an opportunity to learn as much about the genetics of human disease as we have learned in the history of medicine,” the Broad’s Eric ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Tracy Vence

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo